SGT-277

SGT-277
法律規範狀態
法律規範	德：NpSG; 英：Class B;
识别信息
	IUPAC命名法 1-(cyclobutylmethyl)-N-(2-phenylpropan-2-yl)indazole-3-carboxamide; ;
CAS号	3001262-62-7
PubChem CID	155884799;
ChemSpider	90606548;
UNII	3DAF3CP9N5;
CompTox Dashboard (EPA)	DTXSID101336534 ;
化学信息
化学式	C22H25N3O
摩尔质量	347.46 g·mol−1
3D模型（JSmol）	交互式图像;
	SMILES CC(C)(NC(=O)c3nn(CC1CCC1)c2ccccc23)c4ccccc4;
	InChI InChI=1S/C22H25N3O/c1-22(2,17-11-4-3-5-12-17)23-21(26)20-18-13-6-7-14-19(18)25(24-20)15-16-9-8-10-16/h3-7,11-14,16H,8-10,15H2,1-2H3,(H,23,26); Key:CFMZQSDQCNKGII-UHFFFAOYSA-N;

SGT-277，或称为CUMYL-CBMINACA，分子式C
22H
25N
3O，属于吲唑-3-甲酰胺类SGT系列大麻素^[1]，2020年2月首次在德国被发现^[2]。

参考文献

^ Haschimi B, Grafinger KE, Pulver B, Psychou E, Halter S, Huppertz LM, et al. New synthetic cannabinoids carrying a cyclobutyl methyl side chain: Human Phase I metabolism and data on human cannabinoid receptor 1 binding and activation of Cumyl-CBMICA and Cumyl-CBMINACA. Drug Testing and Analysis. August 2021, 13 (8): 1499–1515. PMID 33788409. doi:10.1002/dta.3038 .
^ EU Early Warning System Situation Report. Situation report 1 (PDF). European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). June 2020.